Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Siphesihle Nhlabatsi"'
Autor:
Francesco Schievano, Kissa W. Mwamwitwa, Seth Kisenge, Elice Mmari, Alemayehu Duga, Siphesihle Nhlabatsi, Cassandra Elagbaje, Abiodun Sadikat Abiola, Solomon Getnet Meshesha, Silvia Pagani, Riccardo Lora, Alberto Sabaini, Frank Cobelens, Linda Härmark, Eric Battey Eko, Anita Conforti, Mauro Venegoni, Lara Magro, Ugo Moretti
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
IntroductionEfforts to improve medication access in low-and middle-income countries, particularly in Sub-Saharan Africa, have made progress, especially in the fight against infectious diseases such as tuberculosis. However, challenges exist in establ
Externí odkaz:
https://doaj.org/article/2f90c022a6d946dca96ecd23aef3259b
Autor:
Alemayehu L. Duga, Sibongile Magongo, Siphesihle Nhlabatsi, Denis O. Ladwar, Linda Härmark, Leàn Rolfes
Publikováno v:
AIDS Research and Therapy, Vol 19, Iss 1, Pp 1-5 (2022)
Abstract Background Dolutegravir (DTG) is an Integrase Strand Transfer Inhibitor (INSTI) indicated in combination with other antiretroviral agents for the treatment of HIV infection. It is available in a number of pharmaceutical preparations includin
Externí odkaz:
https://doaj.org/article/5cb433d74cd64154b72ab7ca4d9b0a29
Autor:
Everdina W. Tiemersma, Ibrahim Ali, Asnakech Alemu, Yohanna Kambai Avong, Alemayehu Duga, Cassandra Elagbaje, Ambrose Isah, Alexander Kay, Blandina Theophil Mmbaga, Elice Mmari, Kissa Mwamwitwa, Siphesihle Nhlabatsi, Kassech Sintayehu, Aida Arefayne, Mekonnen Teferi, Frank Cobelens, Linda Härmark
Publikováno v:
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is ty
Externí odkaz:
https://doaj.org/article/75b64751ba39449e81cc8a53ff067b7d
Autor:
Siphesihle Nhlabatsi, Linda Härmark, Aida Arefayne, Asnakech Alemu, Alexander W. Kay, Cassandra Elagbaje, Elice Mmari, Ibrahim Ali, Everdina W. Tiemersma, Frank Cobelens, Mekonnen Teferi, Ambrose O. Isah, Blandina T. Mmbaga, Kassech Sintayehu, Alemayehu Lelisa Duga, Yohanna Kambai Avong, Kissa W. Mwamwitwa
Publikováno v:
BMC health services research, 21(1):1062. BioMed Central
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
BMC Health Services Research
BMC Health Services Research, Vol 21, Iss 1, Pp 1-12 (2021)
Background New medicines have become available for the treatment of drug-resistant tuberculosis (DR-TB) and are introduced in sub-Saharan Africa (SSA) by the national TB programs (NTPs) through special access schemes. Pharmacovigilance is typically t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a976329a2968dde4c77a1cff3b28f8
https://doi.org/10.1186/s12913-021-07043-6
https://doi.org/10.1186/s12913-021-07043-6